ABSTRACT. Proteoglycan was isolated from the epiphyseal cartilage of the knee joint from human fetuses, ranging in age from 11 to 19 wk of gestation. The content of proteoglycan, per wet weight of cartilage, increased with gestational age, and structural changes were observed in the proteoglycan subunits, particularly with respect to hydrodynamic size and the position of sulfation of the chondroitin sulfate chains. While 6-sulfation remained fairly constant on about half the disaccharide residues during the age period examined, the proportion of nonsulfated residues decreased with gestational age and there was a corresponding increase in the proportion of 4-sulfated residues. Other structural parameters showed little change, and after 11 wk of gestation the majority of proteoglycan subunits were able to interact with hyaluronic acid to form aggregates. Link proteins were detected in the cartilage at all ages and their abundance increased with age relative to other cartilage proteins. They showed little change in structural heterogeneity, with the two larger molecular forms predominating. In contrast to the proteoglycans, cartilage proteins were in high abundance at 11 wk of gestation, but decreased considerably with time, although there was little change in the relative proportion of the majority of the components. (Pediatr Res 22: [409][410][411][412][413]1987) 
glycosylation probably reflect a change in the synthetic capacity of the chondrocytes.
The core protein of the proteoglycan subunits also shows structural changes over the same age period. These are reflected in the variation in amino acid composition, although it is still open to question whether the changes reflect the synthesis of unique core proteins or degradation of a common precursor (6) (7) (8) . Irrespective of their origin, the majority of proteoglycan subunits at all ages possesses the ability to interact with hyaluronic acid. Changes due to proteolytic degradation are more definitive in the link proteins, and appear to progress continuously throughout life (9) .
Such changes in proteoglycan structure are not unique to the human, but have also been shown in a variety of animals (10) (11) (12) (13) (14) (15) (16) . Again, the changes in glycosylation appear to be predominant between birth and the end of growth (17) . While the type of changes appears common to all the mammals, the magnitude of the change is variable between the species. Changes during the prenatal period have also been described in bovine cartilage ( I 8-2 1) . From first trimester to birth the size of both the proteoglycan subunits and the chondroitin sulfate chains decreases. There was, however, no change in the sulfation position along the chondroitin sulfate chains, which shows considerable variation after birth. Similarly, the amino acid composition of the core proteins showed little change during the prenatal period. In the human, little information is available for the prenatal period, particularly from mid-first trimester, when the cartilagenous rudiments become evident in the developing limb, to late second trimester. During this period major changes are occumng in the cartilagenous anlage of the long bones, with respect to growth and the development of the osseous diaphysis (22) .
It is also well accepted that genetic abnormalities in the cartilage matrix macromolecules can lead to skeletal dysplasias that are often evident in the fetus. Some such changes are known to affect the proteoglycan subunits. In animals, changes in the expression of the core protein (23, 24) or in the structure of the chondroitin sulfate chains (25, 26) have been shown to produce a disproportionate dwarfism. In the human, such abnormalities are less well characterized, although defects involving proteoglycan have been postulated (27) (28) (29) (30) . Many such genetic abnormalities may be lethal to the fetus and result in premature delivery of a stillborn or a therapeutic abortion. In either case, if one is to study the biochemical origin of the defect it is essential to have normal control tissue of similar gestational age, to eliminate the possibility that structural changes may merely reflect normal embryonic and fetal development rather than be the result of a disease state. The purpose of this work, therefore, was to determine the changes in cartilage proteoglycan structure that may accompany the early developmental stages in the human fetus. Preparation of proteoglycan. Cartilage was obtained from the proximal tibial and distal femoral epiphyses of human fetuses obtained from individuals undergoing therapeutic abortions. Gestational age was assessed from measurement of femoral length (3 l), and tissue was pooled into five groups according to gestational age. The following average age groups were used: 1) 1 1 wk representing eight specimens of 6-7 mm, 2) 13 wk representing three samples of 1 1 -12 mm, 3) 14. Each group represented about 1 g cartilage. The tissue was divided into small pieces (about 1 mm3) and extracted with 4 M guanidinium chloride containing proteinase inhibitors, as described previously (1) . The extract was subjected directly to cesium chloride density gradient centrifugation under dissociative conditions, and proteoglycan subunits and cartilage proteins were recovered from fractions having a density greater than 1.52 glml (Dl preparation) or less than 1.45 g/ml (D3 preparation) respectively.
METHODS

Materials
Analysis ofproteoglycan. Uronic acid content was determined by the carbazole assay (32) and sialic acid by the periodateresorcinol method (33) . Hexosamines and amino acids were determined on a Durrum amino acid analyzer after hydrolysis of samples. Hydrolysis was performed in 4 M HCl for 8 h at 100" C for hexosamine analysis and in 6 M HCl for 20 h at 105" C under a nitrogen atmosphere for amino acid analysis. Protein content was estimated by summation of the amino acids, without correction for losses during the hydrolysis procedure. The position of sulfation of the chondroitin sulfate chains was determined by high-performance liquid chromatography (34) of the unsaturated disaccharides produced by the action of chondroitinase ABC (35) . The chromatography system utilized a LiChrosorb-NH2 column (36) and an acetate buffer system (37) . Proteoglycan size was estimated by chromatography through Sepharose CL-2B as previously described (38) , and the ability to aggregate was assessed by adding 2% hyaluronic acid (w/w) to the sample prior to chromatography.
Electrophoresis. Proteoglycan was analyzed in agarose/polyacrylamide composite gels (39) . After electrophoresis gels were stained with toluidine blue as described previously (1) . Cartilage proteins were analyzed in 10% polyacrylamide gels by the method of King and Laemmli (40) , and stained with Coomassie Brilliant Blue by the method of Fairbanks et al. (41) . Alternatively, protein was transferred from the gel to nitrocellulose by the method of Towbin et al. (42) , and link proteins were specifically visualized by direct immune staining with a monoclonal antibody (913018-A-4), labeled with I2' I by the method of Greenwood et al. (43) , and subsequent autoradiography (44) .
Radioimmunoassay. Monoclonal antibodies were used in competitive assays to detect the presence of fetal and adult type core proteins. Antibody aHFPG-846 recognizes epitopes on proteoglycans from fetal cartilage, and EGF-4 recognizes epitopes on adult proteoglycans (8, 45) . Optimal dilutions of monoclonal antibodies (1/15,000 for EFG-4 and 11400 for aHFPG-846) were incubated with serial dilutions of unlabeled proteoglycans overnight at 37" C, and then with 1251-labeled fetal (23-27 wk gestation) or adult (52-56 yr) cartilage proteoglycans. Immune complexes formed with EGF-4 (IgG1) were precipitated by protein-A bearing Staphylococcus aureus (Zysorbin). Immune complexes formed with aHFPG-846 (IgM) were complexed with rabbit anti-mouse IgM and this tertiary complex was then precipitated with Zysorbin. Percentage inhibition was calculated from the ratio of '251-material precipitated in the presence of unlabeled antigen to that precipitated in its absence.
RESULTS
Proteoglycan subunits were isolated from the epiphyseal cartilage of the knee joint from human fetuses ranging in gestational age from 1 1 to 19 wk. During this time period the yield of the proteoglycan (Dl preparation) increased from 1 1.4 to 29.9 mgl g wet weight of tissue, upon extraction with 4 M guanidinium chloride (Table 1 ). This preparation included the bulk of the uronic acid-containing material in all cases. Analysis of the purified proteoglycan preparations showed increases in the proportion of uronic acid, sialic acid, glucosamine, galactosamine, and protein when measured per dry weight basis, indicating a change in the composition of the preparations. However, when results are expressed relative to the weight of protein the changes are less apparent, suggesting that the degree of glycosylation of the proteoglycan subunits may be similar at all ages.
Some structural changes are, however, apparent. The ratio of galactosamine to glucosamine increased with gestational age, while that of glucosamine to sialic acid decreased ( Table I) . As this latter ratio is always less than 2, there is little evidence for the presence of keratan sulfate of any significant chain length at any age, and the decrease in the ratio suggests that any keratan sulfate is not increasing in abundance with fetal age. While the galactosamine values indicate that chondroitin sulfate is predominant at all ages, the structure of the chains does change markedly with age. At all ages studied, 6-sulfation accounted for about 55% of the disaccharides forming the chondroitin sulfate. With the remaining disaccharides, nonsulfated residues predominated at early points and 4-sulfated residues at later times (Fig. I) . The overall trend then is an increase in the sulfation of the chondroitin sulfate with gestational age, apparently due to the substitution of nonsulfated galactosamine residues with sulfate at their 4-position.
The core protein of the proteoglycans showed only minimal variation in composition with gestational age (Table 2 ). In general there were no consistent trends to prove that multiple core proteins are present, suggesting that any changes in glycosylation may be occurring on a common core protein. Some support for this conclusion was obtained by radioimmunoassay ( Table 3) . The immunological reactivity of the various preparations was similar toward a monoclonal antibody (otHFPG-846) that recognizes a protein-related epitope on fetal human cartilage proteoglycans, and in no case was cross-reactivity observed toward 8 GlcUA, glucuronic acid; NeuAc, N-acetyl neuraminic acid (sialic acid); GlcNAc, N-acetyl glucosamine; GalNAc, N-acetyl galactosamine. Thr  71  72  74  75  74  Ser  117 120  115  109 113  Glu  148 146  148  144 147  Pro  79  84  87  91  89  G~Y  135 134  130  128 127  Ala  77  76  75  77  78  Val  58  61  62  64  63  Met  2  2  2  2  2  Ile  46  46  49  50  47  Leu  77  78  81  84  83  TY r  17  16  17  18  17  Phe  29  28  28  29  29  His  16  16  15  14  14  L Y~  22  20  17  16  17  Arg  29  27  30  29  30 an antibody (EFG-4) that recognizes only the core protein of proteoglycans from adult cartilage (8, 45) . In all cases inhibition curves of the various proteoglycan preparations toward aHFPG-846 were parallel, and with the exception of the preparation from the youngest individuals the amount of material required to give 50% inhibition was similar. Further evidence for the structural similarity between the different proteoglycan preparations was shown by their similar mobilities on agarose/polyacrylamide gel electrophoresis. In all cases only one major component was observed (Table 3) , as is characteristic of third trimester and neonatal cartilage preparations (I). The hydrodynamic size of the proteoglycan subunits showed some changes over the age range studied (Fig. 2) . The average size of the molecules were larger at 14.5 wk than at either 11 or 19 wk, although the difference was not great, with & , , values varying from 0.15 to 0.18 (Table 3 ). In addition, the material from the youngest gestational age appears to show two populations of uronic acid-containing material, with only the larger major population interacting with hyaluronic acid. The older preparations showed only single populations, which interact well with hyaluronic acid (Fig. 2) . The percentage aggregation, measured as the amount of uronic acid-containing material eluting at the void volume on Sepharose CL-2B when chromatography was performed in the presence of hyaluronic acid, was 48% at 1 1 wk gestation and between 70 to 75% at the older ages (Table 3) . t Proportion of uronic acid eluting at the void volume after chromatography through Sepharose CL-2B in the presence of hyaluronic acid. $ Electrophoretic mobility relative to bromophenol blue after electrophoresis on agarose/polyacrylamide gels.
§Amount of proteoglycan required to produce 50% inhibition in a radioimmunoassay using the monoclonal antibody indicated (aHFPG-846 or EFG-4).
11 Not inhibited with up to 1600 ng proteoglycan, whereas 50% inhibition is produced by 60 ng adult proteoglycan.
' FRACTION NUMBER I "0 "I Fig. 2 . Sepharose CL-2B chromatography of proteoglycan subunit preparations. Samples were prepared from fetal cartilage of gestational age a ) 11 wk, b) 14.5 wk, and c) 19 wk. Column emuents were monitored for uronic acid content by the carbazole assay (A530 nm). Chromatography was performed in the absence (-) or presence (---) of 2% w/w hyaluronic acid. The column void volume (V,, 34 ml) and total volume (V,, 88 ml) are indicated.
When the cartilage proteins (D3 preparations) were examined by SDS/polyacrylamide gel electrophoresis, link proteins were found to be present at all ages. They were of similar mobility to their counterparts present in newborn cartilage, although the two larger components predominated (Fig. 3) . As a proportion of the cartilage protein preparation, the abundance of the link proteins increased with gestational age. However, this need not necessarily reflect a change in the total tissue content of link protein, as the cartilage protein preparation yields decreased considerably from 1 1 to 19 wk gestation (Table I) , as previously described in bovine cartilage (19) . At the youngest gestational age the protein accounted for about three times the weight of the proteoglycan, whereas at 19 wk it was only about one-fifth the weight of the proteoglycan. Analysis of the SDS/polyacrylamide gel by Coomassie Brilliant Blue staining showed little difference in relative distribution for the majority of constituent proteins over this age period (Fig. 3) , although some proteins, for example those having molecular weights between 30,000 and 40,000, do show distinct age-related trends. DISCUSSION The results show that over the period of human fetal development from late first trimester (1 1 wk) to mid-second trimester (1 9 wk) changes are occurring in the composition of the cartilage matrix, particularly with respect to the increase in abundance of proteoglycan and the decrease in abundance of cartilage proteins. With further development the proteoglycan and protein content would be expected to increase until birth, with the extractable proteoglycan subunits doubling in concentration from 19 wk gestation to term, when they represent about 60 mg/g wet cartilage in the knee (1) . After birth the concentration of such high-density proteoglycan subunits drops continuously with age to reach about 20 mg/g in the mature adult.
With respect to the proteoglycan subunits themselves there are considerable similarities in some structural parameters, such as the composition of the core protein and the electrophoretic mobility of the molecules. Furthermore, there is little change occurring to these parameters between early third trimester and birth (I), suggesting that during the whole fetal period, the proteoglycan subunits may exist on a single common core protein. A similar situation was also reported in the bovine fetus (1 8) . After birth multiple proteoglycan populations are evident and the structure of the core protein changes considerably. These changes are due partly to variation in the glycosylation pattern of the molecules, particularly in the abundance of chondroitin sulfate and keratan sulfate, and partly to proteolytic modification of the initially produced core protein. The production of genetically distinct core proteins during the period of postnatal development has also been suggested (8) .
The carbohydrate composition of the fetal proteoglycans shows some variations, although at all gestational ages there appears to be a similar content of chondroitin sulfate and little keratan sulfate. This sparsity in keratan sulfate in the human fetus is in contrast to the bovine fetus, where keratan sulfate has been identified throughout fetal development (2 1). In the human, the abundance of chondroitin sulfate and keratan sulfate does not appear to change prior to birth, after which chondroitin sulfate content decreases and keratan sulfate content increases (1). There is, however, considerable variation in the degree and position of sulfation of the chondroitin sulfate chains during the fetal period, with the chains at early periods bearing 25% nonsulfated disaccharide~. The degree of sulfation increases to 85% by 19 wk and 90-95% by birth. During this time the amount of 6-sulfation remains fairly constant but 4-sulfation increases, until by birth it is approaching the level of 6-sulfation. After birth there is little change in the degree of sulfation but 4-sulfation declines continuously to reach about 5% in the adult as 6-sulfation predominates. In the bovine system there is little change in the position of sulfation of chondroitin sulfate isolated from the femoral condyles during fetal development, but the size of the chains decreases (18) . Differences in structural changes during fetal development between the bovine and the human are not surprising in view of the fact that by birth the bovine long bones have epiphyses containing well-developed subchondral bone with articular cartilage on the surface, whereas in the human the secondary centers of ossification are only just developing in the epiphyses and therefore the articular cartilage is still indistinguishable from the bulk of the epiphyseal cartilage.
Link proteins are present at all stages of fetal cartilage development, and as with the newborn three components of molecular weights 48,000, 44,000, and 41,000 are present (46) , although the smallest component, which is thought to be a proteolytic derivative of the larger (47) , is much less abundant. This component increases in concentration during postnatal life (9) together with the production of further fragmented link proteins held in a pseudo-native conformation by disulfide bonds. Such fragmentation was not evident at any stage of fetal development, even though major changes in matrix organization are presumably taking place during this period of rapid growth and development.
It thus appears that structurally the aggregating proteoglycans change little during fetal development, except in their sulfation pattern and possibly their hydrodynamic size. The variation in proteoglycan size is most apparent at the earliest gestational age and may reflect a multiplicity of cell types persisting in the cartilagenous rudiment that has only recently developed from the mesenchyme. Such cellular heterogeneity would be expected to decrease rapidly with fetal development. Such an explanation might also account for other differences between the youngest preparation and its more mature counterparts. The reason for the change in sulfation pattern of the chondroitin sulfate chains remains to be established, as it is not clear whether this could be of any functional significance on the water binding properties of the proteoglycan or its interaction with other matrix components. The other major change, relating to increase in proteoglycan content, is perhaps more expected as the developing cartilage assumes an organization compatible with its functional role after birth, that, at least in the articulating cartilages, requires the water binding and osmotic properties associated with high proteoglycan concentrations (48). It may be significant that the two best described genetic defects relating to proteoglycan structure affect 1) the expression of the core protein, resulting in depleted proteoglycan levels (24), and 2) the sulfation of the chondroitin sulfate chains (25) , indicating the importance of these parameters for normal development.
